Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real Life: Pantoprazole in GERD
NCT00312806Phase 3Completed
- Sponsor
- Takeda
- Start
- May 2006
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 22
01
Overview
A Phase 3 trial of pantoprazole in gastroesophageal reflux disease (GERD), sponsored by Takeda. Started May 2006; status: completed.
02
Drugs
pantoprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00312806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312806.